It has been reported that PRDM5 expression is reduced in human breast cancer, ovarian cancer, and liver cancer, and reintroduction of PRDM5 into ovarian cancer cells causes G2/M cell cycle arrest and apoptotic cell death 14. This evidence concerns the gene PRDM5 and liver cancer.